CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 11 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $48,000 | -91.4% | 30,863 | -90.2% | 0.01% | -93.6% |
| Q1 2021 | $559,000 | +507.6% | 314,000 | +254.0% | 0.11% | +678.6% |
| Q3 2020 | $92,000 | -88.7% | 88,711 | -93.4% | 0.01% | -95.9% |
| Q1 2020 | $813,000 | +27.0% | 1,354,275 | +60.2% | 0.34% | -2.0% |
| Q3 2019 | $640,000 | +2106.9% | 845,432 | +2914.6% | 0.34% | +5650.0% |
| Q4 2018 | $29,000 | +45.0% | 28,045 | +142.5% | 0.01% | +100.0% |
| Q3 2018 | $20,000 | -97.9% | 11,564 | -97.2% | 0.00% | -97.9% |
| Q2 2018 | $937,000 | -76.4% | 407,180 | -68.2% | 0.14% | -38.8% |
| Q1 2018 | $3,976,000 | +384.9% | 1,282,402 | +510.3% | 0.24% | +216.0% |
| Q4 2017 | $820,000 | – | 210,131 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |